0001824293-23-000152.txt : 20230814
0001824293-23-000152.hdr.sgml : 20230814
20230814160620
ACCESSION NUMBER: 0001824293-23-000152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baker David Charles
CENTRAL INDEX KEY: 0001844060
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40034
FILM NUMBER: 231169874
MAIL ADDRESS:
STREET 1: 100 N. 18TH STREET
STREET 2: SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GRI BIO, Inc.
CENTRAL INDEX KEY: 0001824293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824369909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 208
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (619) 400-1171
MAIL ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 208
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: Vallon Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20200910
4
1
wk-form4_1692043540.xml
FORM 4
X0508
4
2023-08-10
0
0001824293
GRI BIO, Inc.
GRI
0001844060
Baker David Charles
C/O GRI BIO, INC.
2223 AVENIDA DE LA PLAYA, SUITE 208
LA JOLLA
CA
92037
1
0
0
0
0
Stock Option (Right to Buy)
2.90
2023-08-10
4
A
0
34483
2.90
A
2033-08-10
Common Stock
34483
34483
D
Vests as to 1/12th of the underlying shares of common stock on the date of grant, then in 11 equal quarterly installments such that the stock option is fully vested on the third annual anniversary of the date of grant.
/s/ Leanne Kelly, Attorney-in-Fact
2023-08-14